1005 – Renal Impairment in People Living With HIV or Receiving PrEP: A Prospective, Matched-Cohort Study
Background HIV preexposure prophylaxis (PrEP) with fixed-dose tenofovir disoproxil fumarate (TDF) and emtricitabine has been associated with relatively low rates of renal impairment in clinical trials, and renal toxicity has been considered less frequent than that observed in people living with HIV (PLWH). Methods In a matched-cohort study, both TDF-treated PLWH and those receiving TDF-based…